Propeller Health, provider of an FDA-cleared digital health solution for improving outcomes in asthma and chronic obstructive pulmonary disease (COPD), today announced a development agreement and R&D collaboration with GSK for its Ellipta® inhaler, the pharmaceutical company’s innovative, patented, dry powder inhaler. Read the full story here.
- Achieving effectiveness at work, home topic at Nov. 5 W·O·M·E·N reception in MadisonOctober 16, 2019
- InWisconsin: Early Stage Symposium connects young companies with investorsOctober 15, 2019
- Fox11News: The business of papermaking: ‘Far from a dying industry’October 14, 2019
- Law Clinic’s co-founder Anne Smith to accept ‘Triple E’ award Nov. 6 at Early Stage eventOctober 11, 2019
- InsideWis: Injecting a dose of urgency: Clinical trials at UW Health get fresh approachOctober 10, 2019